Scolaris Content Display Scolaris Content Display

Poly(ADP‐Ribose) Polymerase (PARP) Inhibitors for locally advanced or metastatic breast cancer

Esta versión no es la más reciente

Appendices

Appendix 1. CENTRAL search strategy

#1 MeSH descriptor: [Breast Neoplasms] explode all trees
#2 local* near advance* near breast near cancer* or locally advance* breast cancer*
#3 local* near advance* near breast near neoplasm* or locally advance* breast neoplasm*
#4 local* near advance* near breast near carcinom* or locally advance* breast carcinoma*
#5 local* near advance* near breast near tumour* or locally advance* breast tumour*
#6 local* near advance* near breast near tumor* or locally advance* breast tumor*
#7 metasta* near breast near cancer* or metastatic breast cancer*
#8 metasta* near breast near neoplasm* or metastatic breast neoplasm*
#9 metasta* near breast near carcinom* or metastatic breast carcinom*
#10 metasta* near breast near tumour* or metastatic breast tumour*
#11 metasta* near breast near tumor* or metastatic breast tumor*
#12 #1 or #2 or #3 or #4 or #5 or #6 or #7 or #8 or #9 or #10 or #11
#13 MeSH descriptor: [Poly(ADP‐ribose) Polymerases] explode all trees
#14 'Poly (ADP‐ribose) Polymerase inhibitor' or Poly (ADP‐ribose) near Polymerase* near inhibitor
#15 PARP* inhibit* or PARP* near inhibit*
#16 veliparib or ABT‐888
#17 olaparib or AZD‐2281
#18 rucaparib or AG014699 or PF‐01367338 or CO‐388
#19 niraparib or MK‐4827
#20 talazoparib or BMN673
#21 E7449 or E7016 or ABT‐767 or BGB‐290
#22 #13 or #14 or #15 or #16 or #17 or #18 or #19 or #20 or #21
#23 #12 and #22

Appendix 2. MEDLINE search strategy

1

randomized controlled trial.pt.

2

controlled clinical trial.pt.

3

randomized.ab.

4

placebo.ab.

5

Clinical Trials as Topic/

6

randomly.ab.

7

trial.ti.

8

(crossover or cross‐over).tw.

9

Pragmatic Clinical Trials as Topic/

10

pragmatic clinical trial.pt.

11

or/1‐10

12

exp Breast Neoplasms/

13

(local$ adj6 advance$ adj6 (breast adj6 (neoplasm$ or cancer$ or carcinoma$ or tumo?r$))).tw.

14

(metasta$ adj6 (breast adj6 (neoplasm$ or cancer$ or carcinoma$ or tumo?r$))).tw.

15

or/12‐14

16

exp "Poly(ADP‐ribose) Polymerases"/

17

"Poly(ADP‐ribose) Polymerase inhibitor".tw.

18

(poly$ adj6 polymerase$ adj6 inhibit$).tw.

19

(poly$ adj6 ribose$ adj6 polymerase$ adj6 inhibit$).tw.

20

(poly$ adj6 ADP$ adj6 polymerase$ adj6 inhibit$).tw.

21

(PARP$ adj6 inhibit$).tw.

22

exp ADP Ribose Transferases/

23

(veliparib or ABT‐888).mp.

24

(olaparib or AZD‐2281).mp.

25

(rucaparib or AG014699 or PF‐01367338 or CO‐388).mp.

26

(niraparib or MK‐4827).mp.

27

(BMN 673 or E7449 or E7016 or ABT‐767 or BGB‐290).mp.

28

or/16‐27

29

and/11,15,28

30

animals/ not (humans/ and animals/)

31

29 not 30

32

limit 31 to yr="2008 ‐Current"

Appendix 3. EMBASE search strategy

#1

random* OR factorial* OR crossover* OR cross NEXT/1 over* OR placebo* OR (doubl* AND blind*) OR (singl* AND blind*) OR assign* OR allocat* OR volunteer* OR 'crossover procedure'/exp OR 'double blind procedure'/exp OR 'randomized controlled trial'/exp OR 'single blind procedure'/exp

#2

'breast'/exp OR 'breast disease'/exp AND 'neoplasm'/exp OR 'breast tumor'/exp OR (breast* NEAR/5 neoplas*):ab,ti OR (breast*NEAR/5 cancer*):ab,ti OR (breast* NEAR/5 carcin*):ab,ti OR (breast* NEAR/5 tumo*):ab,ti OR (breast* NEAR/5 metasta*):ab,ti OR (breast* NEAR/5 malig*):ab,ti

#3

local* AND advance* AND breast NEAR/5 (cancer* OR carcinoma* OR neoplasm* OR tumour* OR tumor*)

#4

local* AND advance* NEAR/5 breast AND (cancer* OR carcinoma* OR neoplasm* OR tumour* OR tumor*)

#5

local* AND advance* NEAR/5 ('breast cancer' OR 'breast carcinoma' OR 'breast neoplasm' OR 'breast tumour' OR 'breast tumor')

#6

'locally advanced breast cancer' OR 'locally advanced breast carcinoma' OR 'locally advanced breast neoplasm' OR 'locally advanced breast tumour' OR 'locally advanced breast tumor'

#7

metasta* AND breast NEAR/5 (cancer* OR carcinoma* OR neoplasm* OR tumour* OR tumor*)

#8

metasta* NEAR/5 breast AND (cancer* OR carcinoma* OR neoplasm* OR tumour* OR tumor*)

#9

metasta* NEAR/5 ('breast cancer' OR 'breast carcinoma' OR 'breast neoplasm' OR 'breast tumour' OR 'breast tumor')

#10

'metastatic breast cancer'/exp OR 'metastatic breast cancer' OR 'metastatic breast carcinoma' OR 'metastatic breast neoplasm' OR 'metastatic breast tumour' OR 'metastatic breast tumor'

#11

#2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR #10

#12

'nicotinamide adenine dinucleotide adenosine diphosphate ribosyltransferase inhibitor'/exp

#13

poly AND 'adp ribose' AND poly* NEAR/6 inhibit* OR poly AND 'adp ribose' AND polymerase AND inhibitor

#14

parp* AND inhibit$ OR parp* NEAR/6 inhibit*

#15

'veliparib'/exp OR veliparib OR 'abt 888'

#16

'olaparib'/exp OR olaparib OR 'azd 2281'

#17

'rucaparib'/exp OR rucaparib OR ag014699 OR 'pf 01367338' OR 'co 388'

#18

'niraparib'/exp OR niraparib OR 'mk 4827'

#19

'talazoparib'/exp OR talazoparib OR bmn AND 673 OR 'bmn673' OR 'bmn 673'

#20

'e7449' OR 'e7016' OR 'abt‐767' OR 'bgb‐290'

#21

#12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19 OR #20

#22

#1 AND #11 AND #21

#23

#22 AND [humans]/lim

#24

#23 AND [embase]/lim AND [2008‐2014]/py

Appendix 4. Search strategy for WHO ICTRP search portal

Basic search

  1. breast cancer AND PARPI

  2. breast cancer AND polymerase inhibitor

  3. breast cancer AND PARP inhibitor

Advanced search

Condition: Breast cancer* OR breast neoplasm* OR breast carcinoma*
Intervention: PARPI* OR PARP inhibitor* OR polymerase inhibitor*
Recruitment status: All studies

Condition: Breast cancer* OR breast neoplasm* OR breast carcinoma*
Intervention: olaparib OR azd 2281 OR rucaparib OR ag014699 OR pf 01367338 OR co 388 OR veliparib OR abt 888 OR niraparib OR mk 4827 OR talazoparib OR bmn 673 or e7449 OR e7016 OR abt‐767 OR bgb‐290
Recruitment status: All studies

Appendix 5. Search strategy for ClinicalTrials.gov

Basic search

  1. breast cancer AND PARPI

  2. breast cancer AND polymerase inhibitor

  3. breast cancer AND PARP inhibitor

Advanced search

Conditions: Breast cancer* OR breast neoplasm* OR breast carcinoma*
Interventions: PARPI* OR PARP inhibitor* OR polymerase inhibitor*
Recruitment: All studies
Study type: Interventional studies

Conditions: Breast cancer* OR breast neoplasm* OR breast carcinoma*
Interventions: olaparib OR azd 2281 OR rucaparib OR ag014699 OR pf 01367338 OR co 388 OR veliparib OR abt 888 OR niraparib OR mk 4827 OR talazoparib OR bmn 673 or e7449 OR e7016 OR abt‐767 OR bgb‐290
Recruitment: All studies
Study type: Interventional studies